ICU Medical, Inc. (ICUI) Misses Q2 EPS by 18c; Cuts FY13 Outlook
ICU Medical, Inc. (NASDAQ: ICUI) reported Q2 EPS of $0.48, $0.18 worse than the analyst estimate of $0.66. Revenue for the quarter came in at $78.7 million versus the consensus estimate of $83.43 million.
ICU Medical, Inc. sees FY2013 EPS of $2.50-2.60, versus prior guidance of $2.70-2.85 and the consensus of $2.81. ICU Medical, Inc. sees FY2013 revenue of $320-325 million, versus prior guidance of $330-337 million and the consensus of $333.64 million.
For earnings history and earnings-related data on ICU Medical, Inc. (ICUI) click here.
ICU Medical, Inc. sees FY2013 EPS of $2.50-2.60, versus prior guidance of $2.70-2.85 and the consensus of $2.81. ICU Medical, Inc. sees FY2013 revenue of $320-325 million, versus prior guidance of $330-337 million and the consensus of $333.64 million.
For earnings history and earnings-related data on ICU Medical, Inc. (ICUI) click here.
